{"id":"https://openalex.org/W1974400848","doi":"https://doi.org/10.2337/diacare.20.2.188","title":"Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone","display_name":"Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone","alternate_titles":[],"publication_year":1997,"publication_date":"1997-02-01","ids":{"openalex":"https://openalex.org/W1974400848","doi":"https://doi.org/10.2337/diacare.20.2.188","mag":"1974400848","pmid":"https://pubmed.ncbi.nlm.nih.gov/9118772"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.20.2.188","doi":"https://doi.org/10.2337/diacare.20.2.188","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.20.2.188","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1974400848"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012360364","display_name":"Tammy K. Antonucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tammy Antonucci","raw_affiliation_strings":["Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045222725","display_name":"Randall W. Whitcomb","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Randall Whitcomb","raw_affiliation_strings":["Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026356141","display_name":"Richard W. McLain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard McLain","raw_affiliation_strings":["Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113443242","display_name":"Dean H. Lockwood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dean Lockwood","raw_affiliation_strings":["Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company\u2008Ann Arbor, Michigan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5161507992","display_name":"R M Norris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R M Norris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.8724,"has_fulltext":false,"cited_by_count":152,"citation_normalized_percentile":{"value":0.99005391,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"20","issue":"2","first_page":"188","last_page":"193"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7842000126838684,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7842000126838684,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.09880000352859497,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0471000000834465,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/impaired-glucose-tolerance","display_name":"impaired glucose tolerance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/troglitazone","display_name":"troglitazone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9990000128746033},{"id":"https://openalex.org/keywords/insulin-sensitizers","display_name":"insulin sensitizers","score":0.7570000290870667},{"id":"https://openalex.org/keywords/oral-glucose-tolerance-test","display_name":"oral glucose tolerance test","score":0.8640000224113464},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.9779999852180481},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.7369999885559082},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7710000276565552},{"id":"https://openalex.org/keywords/fructosamine","display_name":"fructosamine","score":0.9079999923706055}],"concepts":[{"id":"https://openalex.org/C2778150266","wikidata":"https://www.wikidata.org/wiki/Q7844989","display_name":"Troglitazone","level":4,"score":0.9351507425308228},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8505277633666992},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7423887252807617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6994667649269104},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6816220283508301},{"id":"https://openalex.org/C2780609358","wikidata":"https://www.wikidata.org/wiki/Q2087205","display_name":"Impaired glucose tolerance","level":4,"score":0.6032616496086121},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.5583399534225464},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5526743531227112},{"id":"https://openalex.org/C2781357877","wikidata":"https://www.wikidata.org/wiki/Q61913591","display_name":"Fructosamine","level":3,"score":0.5319839715957642},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4805610477924347},{"id":"https://openalex.org/C2780833929","wikidata":"https://www.wikidata.org/wiki/Q1501412","display_name":"Glucose tolerance test","level":4,"score":0.4275570809841156},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.41509705781936646},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.3003847002983093},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2987962067127228},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C127078168","wikidata":"https://www.wikidata.org/wiki/Q138639","display_name":"Peroxisome","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077288","descriptor_name":"Troglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002839","descriptor_name":"Chromans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005006","descriptor_name":"Ethnicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005951","descriptor_name":"Glucose Tolerance Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018149","descriptor_name":"Glucose Intolerance","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2337/diacare.20.2.188","doi":"https://doi.org/10.2337/diacare.20.2.188","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.20.2.188","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:9118772","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9118772","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2335922553","https://openalex.org/W2085390992","https://openalex.org/W2090527653","https://openalex.org/W2053990917","https://openalex.org/W2163007960","https://openalex.org/W2323262681","https://openalex.org/W2381432155","https://openalex.org/W2024947576","https://openalex.org/W2359480301","https://openalex.org/W1992788957"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,88,144,279],"primary":[2],"purpose":[3],"of":[4,12,15,44,54,125,138,170,176,192,194,204,210,226],"this":[5,59],"study":[6,65],"was":[7,92],"to":[8,76,114,182,232],"assess":[9],"the":[10,93,106,119,142,163,211,241,276],"effects":[11],"12":[13,160,202],"weeks":[14,161,169,203],"treatment":[16,165,213,243,270],"with":[17,33,47,294,297],"either":[18,78],"troglitazone,":[19],"an":[20,26],"investigational":[21],"thiazolidinedione":[22],"that":[23],"acts":[24],"as":[25],"insulin-action":[27],"enhancer,":[28],"or":[29,85],"placebo":[30,86,195,229],"in":[31,58,105,162,240],"patients":[32,140,293],"impaired":[34],"glucose":[35,95,120,152,184,218,284],"tolerance":[36,96],"(IGT).":[37],"RESEARCH":[38],"DESIGN":[39],"AND":[40],"METHODS:":[41],"A":[42,136],"total":[43,137],"51":[45],"subjects":[46],"IGT":[48,295],"between":[49],"24":[50],"and":[51,102,109,129,147,159,262,272,288],"77":[52],"years":[53],"age":[55],"were":[56,73,132,154,264],"enrolled":[57],"multicenter,":[60],"double-blind,":[61],"placebo-controlled,":[62],"parallel":[63],"group":[64,214,244],"(troglitazone,":[66],"25":[67],"patients;":[68],"placebo,":[69],"26":[70],"patients).":[71],"Patients":[72],"randomly":[74],"assigned":[75],"receive":[77],"400":[79],"mg":[80],"troglitazone":[81,164,179,212,242],"(every":[82],"morning":[83],"[QAM])":[84],"(QAM).":[87],"main":[89],"outcome":[90],"measure":[91],"oral":[94],"test":[97],"(OGTT)":[98],"assessing":[99],"glucose,":[100,145],"insulin,":[101,146],"C-peptide":[103,148],"levels":[104,124,239],"fasting":[107],"state":[108],"every":[110],"30":[111],"min":[112],"up":[113],"2":[115],"h":[116],"after":[117,150,282],"ingesting":[118],"load.":[121],"Fasting":[122,237],"serum":[123],"HbA1c,":[126],"fructosamine,":[127],"lipids,":[128],"blood":[130,258],"pressure":[131],"also":[133],"measured.":[134],"RESULTS:":[135],"46":[139],"completed":[141],"study.":[143,277],"responses":[149],"a":[151,283],"load":[153,285],"significantly":[155,290],"reduced":[156],"at":[157,266],"6":[158,168],"group.":[166],"After":[167,201],"treatment,":[171,205],"75%":[172],"(n":[173,189,207,223],"=":[174,190,199,208,224,235,253],"18)":[175],"those":[177,193,227],"taking":[178],"had":[180,215,230,245],"improved":[181,291],"normal":[183,233,265,274],"tolerance,":[185,219],"whereas":[186],"only":[187,221],"38%":[188],"9)":[191],"showed":[196],"improvement":[197],"(P":[198,234,252],"0.008).":[200],"80%":[206],"16)":[209],"normalized":[216],"their":[217],"while":[220],"48%":[222],"10)":[225],"on":[228],"converted":[231],"0.016).":[236],"triglyceride":[238],"decreased":[246],"by":[247],"40":[248],"mg/dl":[249],"(0.45":[250],"mmol/l)":[251],"0.0016).":[254],"Other":[255],"lipid":[256],"measurements,":[257],"pressure,":[259],"glycosylated":[260],"hemoglobin,":[261],"fructosamine":[263],"baseline":[267],"for":[268,292],"both":[269],"groups":[271],"remained":[273],"throughout":[275],"CONCLUSIONS:":[278],"glycemic":[280],"response":[281],"is":[286],"statistically":[287],"clinically":[289],"treated":[296],"troglitazone.":[298]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1974400848","counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
